Foster common approaches between People’s Republic of China and the European Union on Personalised Medicine research, development, innovation and policies
News
IC2PerMed’s new publication in Public Health Genomics
IC2PerMed's article "“Integrating China in the International Consortium for Personalized Medicine”: The Coordination and Support Action to [...]
1st Joint Newsletter of IC2PerMed and Sino-EU PerMed
On behalf of IC2PerMed and Sino-EU PerMed projects we are very happy to announce the launch of our [...]
IC2PerMed workshop on EU-China policies and programmes for Personalised Medicine – Mandarin / English – 19/01/2021 – 4:00PM CET
IC2PerMed project will hold its second e-workshop “Policies and programs in the field of Personalized medicine: first results [...]
IC2PerMed at a glance
Supporting International collaboration for the development of Personalised Medicine
The International Consortium for Personalised Medicine (ICPerMed), umbrella initiative of IC2PerMed, aims at initiating and supporting communication and exchange on Personalised Medicine (PM) for aligning national agendas on research and funding activities. It brings together representatives of funding agencies and authorities from 29 countries and expands for increasing PM developments’ synergies at international level.
IC2PerMed project’s core objective is to build upon collaborative developments of Chinese and European experts on PM for elaborating a common strategy, enabling Chinese institutions to join the ICPerMed consortium. The 3 Expert Working Groups will set the path for a common approach of PM research, innovation, development and implementation over the project duration.
